Co-Diagnostics (CODX) to Release Earnings on Thursday

Co-Diagnostics (NASDAQ:CODX) is projected to release its earnings data before the market opens on Thursday, March 13th. Analysts expect Co-Diagnostics to post earnings of ($0.33) per share and revenue of $0.38 million for the quarter.

Co-Diagnostics Price Performance

Shares of CODX opened at $0.50 on Wednesday. The firm has a 50-day moving average of $0.70 and a 200-day moving average of $0.97. Co-Diagnostics has a one year low of $0.46 and a one year high of $2.23. The company has a market cap of $15.95 million, a PE ratio of -0.36 and a beta of 1.29.

Co-Diagnostics Company Profile

Co-Diagnostics, Inc, a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting.